SEC Form 4 · accession 0001209191-15-078458
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jeff L Kogl
Officer — SEE REMARKS
Period of report
Nov 4, 2015
Accepted (ET)
Nov 4, 2015 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.00 | Nov 4, 2015 | A | 100,000 | A | — | Oct 26, 2025 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The option vests 25% of the shares on the first anniversary of October 26, 2015 and with respect to 1/48th of the shares on each monthly anniversary thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Remarks
The Reporting Person is Vice President, Business Development & Strategy of the Issuer.